research Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages
This study found that activating liver X receptors with an agonist reduced skin fibrosis in experimental models, particularly in inflammation-driven conditions, by inhibiting macrophage infiltration and interleukin-6 release.